Rankings
▼
Calendar
ANIK FY 2009 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$204M
FY 2009 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$40M
+12.2% YoY
Gross Profit
$26M
65.9% margin
Operating Income
$6M
13.9% margin
Net Income
$4M
9.2% margin
EPS (Diluted)
$0.32
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
-$867,527
Stock-Based Comp.
$958,025
Balance Sheet
Total Assets
$131M
Total Liabilities
$49M
Stockholders' Equity
$82M
Cash & Equivalents
$24M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$40M
$36M
+12.2%
Gross Profit
$26M
$23M
+17.1%
Operating Income
$6M
$4M
+32.2%
Net Income
$4M
$4M
+1.6%
← FY 2008
All Quarters
FY 2010 →